about
Medical and economic burden of influenza in the elderly population in central and eastern European countries.Early impact of treatment with tiotropium, long-acting anticholinergic preparation, in patients with COPD - real-life experience from an observational study.SOSPES: SPIRIVA® observational study measuring SGRQ score in routine medical practice in Central and Eastern Europe[Lower tract infections as potential indication for therapy with macrolides].Epidemiology of asthma in Poland in urban and rural areas, based on provided health care services.The direct costs of drug-induced skin reactions.Recurrent infections in a patient with psoriatic arthritis and hypogammaglobulinemia, treated with conventional and biologic disease-modifying anti-rheumatic drugs-a primary or secondary entity?[The costs of asthma in Poland in 2012].[Autoimmune connective tissue diseases and vaccination].Drug Policy in Poland.[Evaluation of occurrence frequency of circulating p53 protein in serum of patients with chronic obstructive pulmonary diseases and non-small cell lung cancer].[The effect of inhaled ambroxol treatment on clinical symptoms and chosen parameters of ventilation in patients with exacerbation of chronic obstructive pulmonary disease patients][Retroperitoneal fibrosis--own experience in combined treatment with corticosteroids and tamoxifen].Cc-chemokine eotaxin as a marker of efficacy of specific immunotherapy in patients with intermittent IgE-mediated allergic rhinoconjunctivitis.[Health economic impact of viral respiratory infections and pneumonia diseases on the elderly population in Poland].Association between serum concentrations of eotaxin and testosterone.[Influence of nicotine addiction on telomerase activity in malignant non-small cell lung tumors].Anaphylaxis in Poland: the epidemiology and direct costs.Relationship between serum eotaxins level and their genes expression in skin of atopic dermatitis patients.Clinical and economic impact of a one-year treatment with omalizumab in patients with severe allergic asthma within a drug programme in Poland.[Active tobacco smoking as determinant of costs of inpatient treatment of COPD exacerbations].[Influence of Broncho-Vaxom treatment on serum concentration of metalloproteinase-9 in patients with chronic obstructive pulmonary disease].Telomerase activity and serum levels of p53 protein as prognostic factors of survival in patients with advanced non-small cell lung cancer.Cells of the BAL fluid in patients with acute and chronic bronchitis (preliminary study)[Selected aspects of steroid inhalation the treatment of bronchial asthma][Foreign bodies in the bronchial tree][Cellular analysis of bronchoalveolar lavage fluid (BAL) in patients with acute and chronic bronchitis (preliminary study)][Effect of inhalation therapy with beclomethasone dipropionate on unspecific bronchial hyperreactivity in patients with asthma][T lymphocyte subpopulations OKT-4 and OKT-8 in patients with bronchial asthma][Emergency bronchofibroscopic examination of patients with bronchial asthma and pulmonary fibrosis][Three month treatment with budesonide in patients with corticoid dependent bronchial asthma--personal experience][Macroscopic evaluation of bronchial mucosa and histological diagnosis in relation to localization of neoplastic changes in the bronchial tree][Assessment of skin reactivity in patients with bronchial asthma undergoing non-specific immunotherapy][Granulocyte-macrophage colony stimulating factor (GM-CSF) in material from broncho-alveolar lavage and serum of patients with bronchial asthma][Primary pulmonary lymphoma of the peripheral T lymphocyte type][Usefulness of fine needle biopsy in diagnosis of peripheral lung tumors][Diagnosis and therapy of chronic obstructive pulmonary disease--recommendations of the Polish Phtisiopneumonology Society][Fine needle biopsy in diagnosis of lung tumors][Analysis of measurements: arterial blood pressure, pulse rate and oxygen saturation in arterial blood during broncho-fibroscopy and bronchoalveolar lavage in patients with bronchial asthma and chronic bronchitis][The effect of specific immunotherapy on the concentration of some chemokines in BALF in patients with atopic bronchial asthma]
P50
Q30486450-365E13C1-5095-4866-9ADB-F2F663EC6C63Q35208787-2FB26B3A-A967-4116-A4D8-52B48B1F3F9BQ37249775-2B51225D-FC4C-4514-8DB8-DF0C485A761FQ37855620-0B0D7624-9F37-4E80-AA82-88DEF36A4CE9Q38410305-FA2AFCBA-7D40-4C76-A19B-1AD60D297C25Q38700795-6E2A0C9E-2FE6-42D1-8F5F-A1FE22D42B8DQ39294835-E08915CB-EDE4-4960-BF4C-5D04F4B0C983Q41441024-E595DD32-E471-44E2-8D30-838C5FEB48AEQ41573543-4D051C3B-FD01-4C10-A538-AF8B044E77F0Q42699361-E53C544F-3599-4547-82DA-B48455D521A7Q43057446-F0FC4684-1EC3-41D1-9D4C-52E8EF838F69Q43836629-1D69418D-5D04-47B8-AB49-514CA9E43352Q44415511-070780C0-ACB3-4E08-B6B2-F49E89F146DAQ44488865-825BB2A4-3748-448E-AEF9-3A3F36B6D358Q45107105-46FBEB6C-DCE9-4551-A402-BFF6AA1F62EAQ46914358-9DFF7D36-BF14-4398-A73A-624A6F45AFBEQ46979059-F66441EE-5E34-41D8-B9AE-617588B11FE8Q49393167-C8CE11EA-29AD-4E6C-8050-A5C2473D2998Q50961789-FAB5A4EF-0B2D-4ABE-9C60-0FCDEE025281Q51739239-3338E48B-184B-44CF-B6C1-D4E8D8D64A26Q52287269-661F6139-141C-4766-9179-9653CDAF6405Q53635175-701BD986-E76F-41FB-AA99-0E59943A6B67Q54683152-A97746E3-DEF3-47F4-857E-5D044291C4B6Q67836395-DD8D2BE7-3F72-4D6F-BF0B-C6FB37EDE12BQ67910319-A531FEBD-D866-47FF-9C1B-6E9CBD80A8F6Q68002729-F9F31A9A-9A6A-441F-B983-45DE362B52C0Q68002731-180E7A3F-3501-44AD-8493-DC17AF064599Q68284279-0AD09854-5548-4D15-AEF1-5612DC673A32Q68833594-DF1F0CBE-C637-42FC-A26B-DF1038930CDAQ68899767-3BC1F66C-95BB-4EB5-A6D4-8EF233CAB5BAQ70240827-8BD7DEEE-ECBD-4E85-A0AC-14AC8874BCF4Q70784718-0E911CE4-A45E-4E74-A7DB-725685CBF19AQ71055357-3442F3A7-F2B9-4F56-ABC5-40EAD82CAFA4Q71391304-D5D8DA3F-8318-4984-9159-AA85DF6925A5Q71793063-C8FD5BB5-E8F5-4555-BA05-2EB75E9CC4A7Q72161429-696BAF48-5962-49F5-98E8-D71B66CEC3AAQ73183054-A501E8F7-22E9-455A-AAE8-B71ABAC2B8C7Q73273587-E1341131-9572-4A03-B508-2E97BDFACC70Q73350090-A2666A3C-AA08-4A55-89B0-0015BB8AEAD7Q73350237-D827D010-2069-4CA0-BB9D-D0B1BBFFF547
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究者
@zh
name
Jahnz-Rózyk K
@ast
Jahnz-Rózyk K
@es
Jahnz-Rózyk K
@nl
Karina Jahnz-Rózyk
@en
type
label
Jahnz-Rózyk K
@ast
Jahnz-Rózyk K
@es
Jahnz-Rózyk K
@nl
Karina Jahnz-Rózyk
@en
altLabel
Jahnz-Rózyk K
@en
prefLabel
Jahnz-Rózyk K
@ast
Jahnz-Rózyk K
@es
Jahnz-Rózyk K
@nl
Karina Jahnz-Rózyk
@en
P31
P496
0000-0002-3505-1858